November 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreNovember 13, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreNovember 11, 2025
Market insights predict the global hydrocolloids industry will increase from USD 13.44 billion in 2025 to USD 24.16 billion by 2035, achieving a CAGR of 6.04%. Rising production of pharmaceutical products is promoting the growth of the hydrocolloids market. Europe was dominant due to the high production of hydrocolloids in the region....
November 11, 2025
According to market projections, the diabetic ketoacidosis treatment sector is expected to grow from USD 930.89 million in 2025 to USD 1426.15 million by 2035, reflecting a CAGR of 4.36%. The diabetic ketoacidosis treatment market due to rising investment and collaboration by the major players. North America is leading the market because of t...
November 11, 2025
Projections indicate that, the global allergy diagnostics and therapeutics market will increase from USD 36.55 billion in 2025 to USD 84.59 billion by 2035, experiencing a CAGR of 8.76% over the next 10 years. The market is growing due to the rising prevalence of allergic diseases and increasing demand for advanced diagnostic solutions and personal...
November 10, 2025
Market insights predict the global stem cell therapy industry will increase from USD 613.7 million in 2025 to USD 5835.53 million by 2035, achieving a CAGR of 25.26%. North America led the global stem cell therapy market, while Asia-Pacific is set for strong growth. Allogeneic stem cell therapies dominated, but autologous therapies are expected to ...
November 10, 2025
According to market projections, the influenza vaccine sector is expected to grow from USD 8.49 billion in 2024 to USD 16.73 billion by 2034, reflecting a CAGR of 7.02%. In 2024, North America led the influenza vaccine market (53% share), with Asia Pacific set for the fastest growth. Inactivated vaccines dominated and will see the highest CAGR, whi...
November 10, 2025
Based on market forecasts, the global plastic surgery market, projected at USD 77.42 billion in 2024, is expected to reach USD 217.66 billion by 2034, growing at a CAGR of 11.06% over the forecast period.The market is growing due to rising demand for aesthetic enhancement and increasing acceptance of cosmetic procedures across all age groups. Techn...
November 10, 2025
According to market projections, the global head & neck cancer therapeutics market, valued at USD 2.65 billion in 2025, is anticipated to reach USD 8.14 billion by 2035, growing at a CAGR of 11.87% over the next decade. A surge in tobacco and alcohol consumption and the rising cases of HPV are impacting the global expansion. North America regis...
November 10, 2025
Market insights predict, the clinical nutrition industry is expected to grow from USD 78.15 billion in 2025 to USD 170.12 billion by 2035, driven by a CAGR of 8.1%. The market growth is driven by the rising awareness of the importance of nutritional therapies. The significance of nutritional therapy stems from the growing need to combat malnutritio...
November 07, 2025
Market insights predict the global diabetes management supplements industry will increase from USD 7.17 billion in 2025 to USD 17.7 billion by 2035, achieving a CAGR of 8.65%.The market is growing due to the increasing diabetes population and rising preference for natural blood sugar control products. North America dominates the market owing to hig...
November 07, 2025
According to market projections, the NUT midline carcinoma treatment sector is expected to grow from USD 23.92 billion in 2025 to USD 68.89 billion by 2035, reflecting a CAGR of 11.15%. The growth of the market is driven by innovations in targeted therapies, precision diagnostics, and increased global focus on rare oncologic indications. North Amer...